METHOD OF ASSUMING DRUG SENSITIVITY TO CDK4 INHIBITOR
First Claim
Patent Images
1. A gene for assuming drug sensitivity, which is to be used for assuming the drug sensitivity to a CDK4 inhibitor based on the expression amount in a test tissue or a test cell, selected from the group consisting of p16 gene, p18 gene and p27 gene.
2 Assignments
0 Petitions
Accused Products
Abstract
It is intended to provide a gene for assuming drug sensitivity, which is to be used for assuming the drug sensitivity to a CDK4 inhibitor based on the expression amount in a test tissue or a test cell, selected from the group consisting of p16 gene, p18 gene and p27 gene. It is also intended to provide a method of assuming the drug sensitivity to a CDK4 inhibitor by using the expression amount of the above gene in a test tissue or a test cell as an indication.
7 Citations
12 Claims
- 1. A gene for assuming drug sensitivity, which is to be used for assuming the drug sensitivity to a CDK4 inhibitor based on the expression amount in a test tissue or a test cell, selected from the group consisting of p16 gene, p18 gene and p27 gene.
-
4. A reagent for detection of drug sensitivity to a CDK4 inhibitor containing an antibody which specifically recognizes an antisense nucleic acid of gene selected from the group consisting of p16 gene, p18 gene and p27 gene or protein expressed by said gene.
-
5. An antisense nucleic acid of a gene selected from the group consisting of p16 gene, p18 gene and p27 gene.
-
7. A method of measuring the drug sensitivity to a CDK4 inhibitor comprising the steps of:
-
measuring the expression amount of at least one gene selected from the group consisting of p16 gene, p18 gene and p27 gene in a test tissue or in a test cell and comparing the expression amount of said gene with the expression amount of said gene in a healthy tissue or in a healthy cell. - View Dependent Claims (8, 11)
-
- 9. A method of assuming drug sensitivity to a CDK4 inhibitor including a step where expression of at least one gene selected from the group consisting of p16 gene, p18 gene and p27 gene in a test tissue or a test cell is detected.
-
12. Use of a gene selected from the group consisting of p16 gene, p18 gene and p27 gene for assuming drug sensitivity to a CDK4 inhibitor based on the expression amount in a test tissue or a test cell.
Specification